The expression and purification of the N-terminal activation domain of the transcription factor c-Myc: a model

William F Waas1, Kevin N Dalby

  • 1Division of Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, TX 78712, USA.

Insights

Researchers developed an efficient method to purify the c-Myc activation domain for studying its interaction with ERK2, a key enzyme in cell signaling. This purification enables detailed mechanistic and biophysical investigations into how ERK2 recognizes and phosphorylates c-Myc.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Signaling

Background:

  • ERK2 (a MAPK) is crucial for cell signal transduction, influencing proliferation and differentiation.
  • ERK2 phosphorylates the transcription factor c-Myc at Ser-62, enhancing its stability and promoting cell cycle progression.
  • The precise mechanism of c-Myc recognition by ERK2 remains unclear.

Purpose of the Study:

  • To develop a rapid and efficient purification method for the c-Myc activation domain (residues 2-99).
  • To enable structural and kinetic studies of the ERK2-c-Myc interaction.
  • To facilitate mechanistic and biophysical investigations into ERK2 substrate recognition.

Main Methods:

  • Expression of GST-c-Myc(Delta2-99)-His(6) in Escherichia coli.
  • Purification using glutathione-agarose and nickel-agarose affinity chromatography.
  • Enzymatic characterization of ERK2 phosphorylation of purified c-Myc(Delta2-99)-His(6).

Main Results:

  • A high-yield purification protocol yielded 8 mg of (c-MycDelta2-99)-His(6) per liter of culture.
  • Kinetic parameters for ERK2 phosphorylation were determined: k(cat)=10.4s(-1) and K(M)(c-Myc)=57.4 microM.
  • The developed method provides a reliable source of purified c-Myc activation domain for further studies.

Conclusions:

  • A streamlined purification strategy for the c-Myc activation domain has been established.
  • This preparation is suitable for detailed mechanistic and biophysical studies of ERK2.
  • Understanding ERK2-c-Myc interactions is critical for deciphering cell cycle regulation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...